Futura Medical Regulatory News (FUM)

24 November 2017

Name of company:

Futura Medical plc

Name of scheme:

Unapproved Share Option Scheme ("USOS")EMI Share Option Scheme ("EMI")

Period of return:

From:

25 May 2017

To:

24 November 2017

Number and class of securities not issued under the scheme(s) at start of period

USOS:

2,446,110

EMI:

3,021,390

Total:

5,467,500

Number of securities issued under the scheme(s) during the period

Number of securities lapsed under the scheme(s) during the period

USOS:

-

EMI:

USOS:

EMI:

-

50,000

350,000

Balance under the scheme(s) of securities not yet issued at the end of the period

USOS:

2,396,110

EMI:

2,671,390

Total:

5,067,500

Number and class of securities originally admitted and the date of admission

USOS:

814,424 on 25 May 2011, 1,202,280 on 8 October 2013, 1,466,208 on 25 May 2017

USOS Total:

3,482,912

EMI:

1,520,576 on 25 May 2011, 1,467,720 on 8 October 2013

1,893,792 on 25 May 2017

EMI Total:

4,882,088

Total:

8,365,000

Name of contact:

Derek Martin, Chief Financial Officer

Telephone number of contact:

+44 (0) 1483 685 670

Futura Medical plc

James Barder, Chief Executive

Tel: +44 (0) 1483 685 670

Email to: james.barder@futuramedical.com

www.futuramedical.com

N+1 Singer (Nominated Adviser and Broker)

Aubrey Powell / Liz Yong

Corporate Finance

Tel:+44 (0) 20 7496 3000

For media enquiries please contact:

Buchanan

Mark Court / Sophie Cowles / Stephanie Watson

Tel: +44 (0) 20 7466 5000